Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
First described by Novo Nordisk researchers, ipamorelin is notable for its selectivity in stimulating growth hormone release without significantly affecting other pituitary hormones such as ACTH, prolactin, FSH, LH, or TSH in preclinical models
Kuang F, Liu J, Li C, Kang R, Tang D
Lund Toxicology Reports.2026
Legal & Safety Information Research Use Only This product is supplied strictly for laboratory research purposes, supporting scientific and analytical applications under controlled conditions
The information below is provided as an honest informational comparison for patients researching their growth hormone peptide options
Subsequent investigational work explored ghrelin-receptor agonists like ipamorelin for conditions such as postoperative ileus, but ipamorelin never reached an approved marketed indication
US$ 23.85
US$ 24.72
US$ 28.80
US$ 27.42
US$ 22.55
